CELLECTIS (ALCLS.PA) Forecast, Price Target & Analyst Ratings

EPA:ALCLSFR0010425595

Current stock price

3.15 EUR
-0.04 (-1.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CELLECTIS (ALCLS.PA).

Forecast Snapshot

Consensus Price Target

Price Target
€6.63
+ 110.48% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 19, 2026
Period
Q4 / 2025
EPS Estimate
-$0.26
Revenue Estimate
12.813M

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€6.63
Upside
+ 110.48%
From current price of €3.15 to mean target of €6.63, Based on 13 analyst forecasts
Low
€6.57
Median
€6.63
High
€6.83

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for ALCLS.PA. The average price target is 6.63 EUR. This implies a price increase of 110.48% is expected in the next year compared to the current price of 3.15.

Analyst Ratings & History

Current Analyst Ratings

ALCLS Current Analyst RatingALCLS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ALCLS Historical Analyst RatingsALCLS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
ALCLS.PA was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALCLS.PA.
In the previous month the buy percentage consensus was at a similar level.
ALCLS.PA was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 19, 2026
Period
Q4 / 2025
EPS Estimate
-$0.26
Revenue Estimate
12.813M
Revenue Q2Q
-15.51%
EPS Q2Q
-430.89%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

ALCLS.PA is expected to report earnings on 3/19/2026. The consensus EPS estimate for the next earnings is -0.26 EUR and the consensus revenue estimate is 12.81M EUR.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ALCLS.PA revenue by date.ALCLS.PA revenue by date.
25.725M
-33.35%
9.193M
-64.26%
49.217M
435.37%
69.087M
40.37%
63.747M
-7.73%
44.805M
-29.71%
82.398M
83.90%
82.976M
0.70%
186.82M
125.15%
224.24M
20.03%
296.41M
32.18%
EBITDA
YoY % growth
ALCLS.PA ebitda by date.ALCLS.PA ebitda by date.
-71.231M
18.04%
-78.779M
-10.60%
-39.708M
49.60%
-69.319M
-74.57%
-113.3M
-63.45%
-155.53M
-37.27%
-183.463M
-17.96%
N/AN/AN/AN/A
EBIT
YoY % growth
ALCLS.PA ebit by date.ALCLS.PA ebit by date.
-89.666M
13.35%
-97.302M
-8.52%
-59.554M
38.79%
-67.621M
-13.54%
-100.93M
-49.26%
-178.19M
-76.55%
-43.229M
75.74%
-32.625M
24.53%
50.869M
255.92%
87.024M
71.07%
137.1M
57.54%
Operating Margin
ALCLS.PA operating margin by date.ALCLS.PA operating margin by date.
-348.56%-1,058.44%-121.00%-97.88%-158.33%-397.70%-52.46%-39.32%27.23%38.81%46.25%
EPS
YoY % growth
ALCLS.PA eps by date.ALCLS.PA eps by date.
-2.37
39.26%
-1.78
24.77%
-0.35
80.34%
-0.94
-167.21%
-1.18
-26.29%
-1.44
-21.66%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.26
-430.89%
-0.25
-41.63%
-0.28
-18.74%
-0.23
-2,400.30%
-0.24
10.51%
-0.24
5.45%
-0.49
-72.05%
0.02
107.61%
0.40
267.83%
Revenue
Q2Q % growth
12.813M
-15.51%
17.789M
47.88%
11.361M
-37.55%
19.498M
-47.54%
35.72M
178.78%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-12.365M
41.12%
-13.937M
1.71%
-14.902M
37.30%
-10.251M
-227.48%
-15.197M
-22.90%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ALCLS.PA Yearly Revenue VS EstimatesALCLS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
ALCLS.PA Yearly EPS VS EstimatesALCLS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-60.12%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-0.03%
Revenue Next 5 Year
13.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-33.24%
EBIT Next 5 Year
-29.24%

CELLECTIS / ALCLS.PA Forecast FAQ

Can you provide the average price target for CELLECTIS stock?

13 analysts have analysed ALCLS.PA and the average price target is 6.63 EUR. This implies a price increase of 110.48% is expected in the next year compared to the current price of 3.15.

When does CELLECTIS (ALCLS.PA) report earnings?

CELLECTIS (ALCLS.PA) will report earnings on 2026-03-19, after the market close.

What are the consensus estimates for ALCLS stock next earnings?

The consensus EPS estimate for the next earnings of CELLECTIS (ALCLS.PA) is -0.26 EUR and the consensus revenue estimate is 12.81M EUR.

Can you provide the expected long term growth rate for CELLECTIS stock?

The expected long term growth rate for CELLECTIS (ALCLS.PA) is -0.03%.